March 19, 2018. We support the USPSTF draft recommendation for behavior-based interventions for weight loss to prevent obesity-related health problems and death. We further support USPSTF’s efforts to improve the health of all Americans by making evidence-based recommendations about clinical preventive services. As more information becomes available, we encourage the re-evaluation and potential development of additional recommendation to improve the health of individuals with weight-related health concerns.
Read More »On Health Policy
Statement on Failure of “Right to Try” Bill
March 13, 2018. We thank Congress for rejecting the dangerous and misnamed “Right to Try” bill yesterday. The bill would harm more patients than it would help.
Read More »NCHR Letter to Maryland on State Funding for Artificial Turf and Playgrounds
March 5, 2018. The State of Maryland has many spending priorities and should not be spending millions of dollars for artificial turf fields and playgrounds that can exacerbate our children’s health problems now, and potentially cause them to develop cancer in the years to come. Let’s instead invest in safe, natural playing fields, unless any synthetic alternatives are proven in unbiased research to be as safe and as cost-effective as grass for fields and engineered wood fiber for playgrounds.
Read More »NCHR Comments to USPSTF on Syphilis Screening During Pregnancy
March 5, 2018. The prevention of congenital syphilis and other negative fetal outcomes outweighs the risks of false results or unnecessary treatment with penicillin, especially when screening occurs early in the pregnancy. Overall, we agree with the USPSTF draft recommendation for syphilis screening in pregnant women.
Read More »NCHR Comments at the Risk Communication Advisory Committee on Pregnancy and Lactation Labeling Rule
March 5, 2018. Pregnancy/postpartum represent critical periods for counseling, health promotion, and health maintenance. Providers and patients must engage in informed discussions of benefits, risks, and alternatives in order to achieve shared-decision making. However, uncertainty of drug harms present a unique challenge in the overall picture of risks and benefits.
Read More »